US Food And Drug Administration Approves RECOTHROM; »
Posted by: fromhell 2 months agoBayer HealthCare announced that its partner, ZymoGenetics Inc., received US Food and Drug Administration (FDA) approval of RECOTHROM; Thrombin, topical (recombinant) for use as a topical hemostatic product. Bayer acquired the product rights for all markets outside the US in 2007 and will provide US sales support for a three-year period a
Read Full Story at allmedicalnews.com
Submitted By:
fromhell
Related Articles:
Why not submit a story?
Also Propping This Article
Groups Watching This
No groups are watching this story. Why not share it with your group?
